Because there is a lack of data evaluating the expression of phospho-FAK in human lung cancer tissues as opposed to total FAK expression [19,33,34], we aimed to evaluate the expression of phospho-FAK (Y397) in SCLC and NSCLC tissues, and correlate the data to patients’ prognosis. This evidence concerns the gene PTK2 and lung carcinoma.